Novozymes A/S
XBER:NZM2
Novozymes A/S
XBER:NZM2
Price:
54.62
EUR
Market Closed
Market Cap:
€15.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Novozymes A/S
XBER:NZM2
|
DK |
|
G
|
Galapagos NV
SWB:GXE
|
BE |
|
Glencore PLC
LSE:0IVW
|
CH |
|
Bioporto A/S
OTC:THOXF
|
DK |
|
S
|
SoftBank Group Corp
LSE:0R15
|
JP |
|
L
|
Loop Industries Inc
XBER:3L9
|
CA |
|
A
|
Alcoa Corp
ASX:AAI
|
US |
|
V
|
Vishay Intertechnology Inc
SWB:VHY
|
US |
|
E
|
Eastgroup Properties Inc
F:EGO
|
US |
|
R
|
Realtech AG
SWB:RTC
|
DE |
|
Ford Motor Co
NYSE:F
|
US |
|
Caixabank SA
MAD:CABK
|
ES |
|
M
|
Molina Healthcare Inc
XBER:MHG
|
US |
|
M
|
Mondi PLC
JSE:MNP
|
UK |
|
A
|
ArcBest Corp
F:AQY
|
US |
|
A
|
AES Corp
F:AES
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NZM2's stock price target?
Not Available
NZM2 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Novozymes A/S?
Projected CAGR
-55%
-55%
Over the last 7 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 2 years is -55%.
What is the Net Income forecast for Novozymes A/S?
Projected CAGR
-56%
-56%
Over the last 7 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 2 years is -56%.
